Research shows health professionals ‘cool’ on legal controls of risk-laden fertility treatment (AlphaGalileo, 20 March 2013)
Novo Nordisk says trial shows Victoza helps patients lose weight (Bloomberg, 18 March 2013)

NPS regains right to drugs from Takeda for $50 mln in NPS shares (Reuters, 19 March 2013)

20 Mar 2013

NPS Pharmaceuticals Inc has regained worldwide rights to teduglutide (Revestive) for short bowel syndrome and a parathyroid hormone formulation (Preotact) for osteoporosis.

Full article

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read